Loading...
XKRX
084110
Market cap477mUSD
Dec 05, Last price  
57,500.00KRW
1D
6.09%
1Q
28.21%
Jan 2017
84.82%
IPO
60.69%
Name

Huons Global Co Ltd

Chart & Performance

D1W1MN
XKRX:084110 chart
P/E
27.31
P/S
0.87
EPS
2,105.72
Div Yield, %
0.96%
Shrs. gr., 5y
0.40%
Rev. gr., 5y
12.60%
Revenues
813.46b
+7.26%
134,072,148,320158,182,764,740182,342,752,70065,448,158,240163,712,232,478323,960,589,100378,687,481,597449,422,998,381523,047,736,598574,647,694,739664,364,718,200758,379,661,000813,460,515,000
Net income
25.79b
-32.81%
6,667,122,97017,382,520,47020,932,848,10032,384,338,35322,821,238,86825,764,228,74729,160,495,87226,657,291,36742,695,966,6903,994,540,840-60,254,134,70538,383,627,22025,791,032,000
CFO
100.57b
+0.60%
18,044,646,53024,806,033,55028,792,391,07050,908,903,22919,383,639,00047,518,191,47653,574,796,36465,546,999,03190,591,629,97749,821,824,90564,373,889,77799,967,135,360100,571,082,000
Dividend
Jun 27, 2024275 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Huons Global Co., Ltd. provides medical solutions for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, adrenocortical hormone, enzyme, mineral, solvent, calcium, hemostatic, antidote, antibiotic, metabolic, hyaluronic acid, well-being, anticoagulant, and others, as well as circulatory, respiratory, and other tissue cell systems. It also provides medical devices, eye drop products, and bio products. The company was formerly known as Huons Co., Ltd. and changed its name to Huons Global Co., Ltd. in June 2016. Huons Global Co., Ltd. was founded in 1965 and is headquartered in Seongnam, South Korea.
IPO date
Dec 19, 2006
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT